Close Menu

NEW YORK – Trapelo Health and the Magellan Rx Management pharmacy benefits management arm of Magellan Health on Thursday announced plans to bundle their technologies to build a platform to support value-based precision oncology care.

Trapelo, of Burlington, Massachusetts, makes a clinical decision support system that links healthcare providers, testing laboratories, and payors, giving them access to molecular testing information, ordering, and results interpretation in order to optimize utilization of molecular testing services and offer the most appropriate care to patients.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.